Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis.
about
Pharmacological treatments for preventing epilepsy following traumatic head injuryAntiepileptic drugs for the primary and secondary prevention of seizures after subarachnoid haemorrhageRole of Anticonvulsants in the Management of Posttraumatic Epilepsy.Neurobehavioral effects of levetiracetam in patients with traumatic brain injuryPhenytoin versus Leviteracetam for seizure prophylaxis after brain injury - a meta analysisTraumatic Brain Injury pathophysiology and treatments: early, intermediate, and late phases post-injuryPost-traumatic epilepsy: current and emerging treatment options[Aneurysmal subarachnoid hemorrhage].The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments.Emergency treatment with levetiracetam or phenytoin in status epilepticus in children-the EcLiPSE study: study protocol for a randomised controlled trialThe Art of Managing Conversions between Antiepileptic Drugs: Maximizing Patient Tolerability and Quality of Life.Continuous Electroencephalography (cEEG) Monitoring and Outcomes of Critically Ill Patients.Cost-effectiveness analysis of intravenous levetiracetam versus intravenous phenytoin for early onset seizure prophylaxis after neurosurgery and traumatic brain injuryFrequency and timing of nonconvulsive status epilepticus in comatose post-cardiac arrest subjects treated with hypothermiaIs There Equipoise Between Phenytoin and Levetiracetam for Seizure Prevention in Traumatic Brain Injury?Pharmacologic Neuroprotection for Functional Outcomes After Traumatic Brain Injury: A Systematic Review of the Clinical Literature.Levetiracetam Versus Phenytoin for Seizure Prophylaxis Following Traumatic Brain Injury: A Systematic Review and Meta-Analysis.Levetiracetam Extended Release as Adjuvant Therapy for the Control of Partial-onset Seizures.Role of intravenous levetiracetam in seizure prophylaxis of severe traumatic brain injury patients.Prospects of levetiracetam as a neuroprotective drug against status epilepticus, traumatic brain injury, and strokeEthosuximide and phenytoin dose-dependently attenuate acute nonconvulsive seizures after traumatic brain injury in rats.Variation in Anticonvulsant Selection and Electroencephalographic Monitoring Following Severe Traumatic Brain Injury in Children-Understanding Resource Availability in Sites Participating in a Comparative Effectiveness Study.Contemporary pharmacologic issues in the management of traumatic brain injury.Seizures and anticonvulsants after aneurysmal subarachnoid hemorrhage.Levetiracetam compared with valproic acid for the prevention of postoperative seizures after supratentorial tumor surgery: a retrospective chart review.Levetiracetam use in the critical care setting.Seizure prophylaxis in neurocritical care: a review of evidence-based support.Retrospective analysis of levetiracetam compared to phenytoin for seizure prophylaxis in adults with traumatic brain injury.Long-term comparison of GOS-E scores in patients treated with phenytoin or levetiracetam for posttraumatic seizure prophylaxis after traumatic brain injury.Continuous EEG monitoring in aneurysmal subarachnoid hemorrhage: a systematic review.Levetiracetam versus phenytoin for seizure prophylaxis in brain injured patients: a systematic review and meta-analysis.Cardiovascular adverse effects of phenytoin.Prophylactic Anticonvulsants in Intracerebral Hemorrhage.Efficacy and safety of prophylactic levetiracetam in supratentorial brain tumour surgery: a systematic review and meta-analysis.Evolving use of seizure medications after intracerebral hemorrhage: A multicenter study.The safety and efficacy of levetiracetam versus phenytoin for seizure prophylaxis after traumatic brain injury: A systematic review and meta-analysis.Should Levetiracetam or Phenytoin Be Used for Posttraumatic Seizure Prophylaxis? A Systematic Review of the Literature and Meta-analysis.Noninvasive Neuromonitoring: Current Utility in Subarachnoid Hemorrhage, Traumatic Brain Injury, and Stroke.Drug Interactions in Neurocritical Care.Abbreviated levetiracetam treatment effects on behavioural and histological outcomes after experimental TBI.
P2860
Q24187948-39FD061F-897C-4D02-98FD-8D686602F9CAQ24202269-0EC1C4C1-057C-4A05-84D3-7EFE71DA81EFQ26752356-D918CCB0-1220-4C47-B632-EE91FEE2D2C3Q26830325-87A18A39-C6DB-45C3-9DEE-CC2AB90398D6Q26991613-E4C401AC-FCE0-4144-9508-F3588C3E51E8Q27001739-8CE98346-44EC-4C77-B5C3-B0D8191A28EEQ27004055-BAD2BE71-AE0C-4DA3-BFB8-9752C8180F61Q30317996-B8EDC534-72AC-406D-A611-790CBA16E68DQ30576758-AE668394-EBE9-4D01-8CF5-1C509740F825Q33814309-E4E83EA3-A071-496D-A15F-BA058F8DE28CQ34158012-E7CE1AA2-E03B-4EB0-B603-0E066145E5C3Q34550609-4F9D8E47-1A91-4556-9E73-3B3BF0DE751CQ35205335-D143512A-AB4B-4F7D-A3B4-EAF7BF8C4F15Q35281450-55A8B4B4-35C4-4197-9D37-2B023D503528Q35900323-1313DB6A-A43A-470C-A2D6-0ADAC47C8A5BQ36060634-08882D7F-0EE9-4C5A-B2BB-A2448FCC2D6EQ36072176-6E82EFDC-2458-40BA-81AB-1B1EBBD9A881Q36873888-22DD6213-501F-4486-B0FE-9F3F0DD9BECDQ37271469-FD79FC1D-C558-4CE9-945A-8C127E096B81Q37276387-2B92913B-5A31-43B7-962B-C90E3E9D3A7FQ37334696-8CAB94C2-2BB2-4FF2-9EE5-A744A00EF452Q37536046-28B0B938-B5CA-4448-9391-358B084E07F1Q37867299-B5FF7ACB-36F9-4865-91F9-F6B8D4867EA3Q37900528-8AA7EAB9-DD99-4C7A-9882-27B1DB23814EQ38127128-98FEC64D-E86C-493F-A662-6E453044458FQ38132386-3690F537-7AFA-49DA-B099-9ABC0E4C7B72Q38166331-25531CA7-90C2-43E2-A7B7-740D1E49DB95Q38178244-0D038207-5D7A-41B7-9B14-78FA7A7D9A94Q38244403-96C0BC16-F67A-4B33-A012-359C656EA579Q38256256-2147DE8E-8530-43BA-9777-E3C009811073Q38638515-4E90D4E6-E9ED-4649-B2BD-7862B4748C35Q38662067-90BF08ED-EF65-4E60-BB40-98F6B3E4B6F7Q38742170-033519F9-F7E3-4EA0-A13C-2FB6917F47E2Q38761893-8F8CFF9A-87D3-4943-9A4F-682149F5D101Q38793438-E19F11DE-F44F-4ABC-A943-50061CFEF621Q38863477-632EDC08-5A88-4D28-A566-20A672FC4AB7Q38982794-C3C49A31-F141-4BEA-9350-26E9A43454BAQ39048366-99BA003E-BF84-4042-8003-1772091A58F7Q39067987-6E2EDBCC-8CD7-4BDF-8CDD-7502A0BE98E1Q39123432-BDAC0F63-FBCC-46F1-9E5E-2C3C4C9EC1AE
P2860
Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Prospective, randomized, singl ...... ytoin for seizure prophylaxis.
@en
Prospective, randomized, singl ...... ytoin for seizure prophylaxis.
@nl
type
label
Prospective, randomized, singl ...... ytoin for seizure prophylaxis.
@en
Prospective, randomized, singl ...... ytoin for seizure prophylaxis.
@nl
prefLabel
Prospective, randomized, singl ...... ytoin for seizure prophylaxis.
@en
Prospective, randomized, singl ...... ytoin for seizure prophylaxis.
@nl
P2860
P1433
P1476
Prospective, randomized, singl ...... ytoin for seizure prophylaxis.
@en
P2093
Jerzy P Szaflarski
Kiranpal S Sangha
P2860
P2888
P304
P356
10.1007/S12028-009-9304-Y
P577
2010-04-01T00:00:00Z